Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

被引:0
|
作者
Prooksa Ananchuensook
Supachaya Sriphoosanaphan
Sirinporn Suksawatamnauy
Nipaporn Siripon
Nutcha Pinjaroen
Nopavut Geratikornsupuk
Stephen J. Kerr
Kessarin Thanapirom
Piyawat Komolmit
机构
[1] Chulalongkorn University,Division of Gastroenterology, Department of Medicine, Faculty of Medicine
[2] King Chulalongkorn Memorial Hospital,Center of Excellence in Liver Diseases
[3] Thai Red Cross Society,Liver Fibrosis and Cirrhosis Research Unit
[4] Chulalongkorn University,Department of Radiology, Faculty of Medicine
[5] Chulalongkorn University,Department of Medicine
[6] Queen Savang Vadhana Memorial Hospital,Center of Excellence in Biostatistics, Faculty of Medicine
[7] Chulalongkorn University,undefined
来源
BMC Gastroenterology | / 22卷
关键词
Easy albumin-bilirubin score; Intermediate-stage hepatocellular carcinoma; Trans-arterial chemoembolization; Overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy
    Chen, Zhan-Hong
    Hong, Ying-Fen
    Chen, Xiangwei
    Chen, Jie
    Lin, Qu
    Lin, Jinxiang
    Li, Xing
    Wen, Jing-Yun
    Ruan, Dan-Yun
    Dong, Min
    Wei, Li
    Wang, Tian-Tian
    Lin, Ze-Xiao
    Ma, Xiao-Kun
    Wu, Dong-Hao
    Wu, Xiang-Yuan
    Xu, Ruihua
    ONCOLOGY LETTERS, 2018, 15 (01) : 855 - 862
  • [42] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Caihua Zhu
    Bing Dai
    Hua Zhan
    Ruoyu Deng
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1065 - 1071
  • [43] Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma
    Xie, Hui
    Tian, Shengtao
    Cui, Li
    Yan, Jieyu
    Bai, Yanhua
    Li, Xiaohui
    Wang, Maoqiang
    Zhang, Fangfang
    Duan, Feng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4065 - 4073
  • [44] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Zhu, Caihua
    Dai, Bing
    Zhan, Hua
    Deng, Ruoyu
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1065 - 1071
  • [45] Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate-stage hepatocellular carcinoma: A pilot study
    Huo, Haoran
    Wang, Xiaoying
    Xu, Shan
    Niu, Xiaotong
    Cheng, Limin
    Yuan, Zengjiang
    Huo, Shuang
    Fang, Pingping
    ONCOLOGY LETTERS, 2023, 26 (05)
  • [46] Development of a Prognostic Nomogram in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Following Trans-Arterial Chemoembolization with Drug-Eluting Beads
    Cheng, Sihang
    Yu, Xiang
    Liu, Siyun
    Jin, Zhengyu
    Xue, Huadan
    Wang, Zhiwei
    Xie, Ping
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9367 - 9377
  • [47] Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma
    Lee, Sung Won
    Lee, Hae Lim
    Han, Nam Ik
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 81 - 88
  • [48] Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis
    Liu, Meng-Meng
    Chen, Zhan-Hong
    Zhao, Li-Yun
    Zhao, Jing-Yuan
    Rong, Dai-Lin
    Ma, Xiao-Kun
    Ruan, Dan-Yun
    Lin, Jin-Xiang
    Qi, Jing-Jing
    Hu, Pei-Shan
    Wen, Jing-Yun
    Chen, Jie
    Lin, Qu
    Wu, Xiang-Yuan
    Wei, Li
    Dong, Min
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (09) : 450 - 463
  • [49] Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
    Shimose, Shigeo
    Iwamoto, Hideki
    Tanaka, Masatoshi
    Niizeki, Takashi
    Shirono, Tomotake
    Noda, Yu
    Kamachi, Naoki
    Okamura, Shusuke
    Nakano, Masahito
    Suga, Hideya
    Yamaguchi, Taizo
    Kawaguchi, Takumi
    Kuromatsu, Ryoko
    Noguchi, Kazunori
    Koga, Hironori
    Torimura, Takuji
    CANCERS, 2021, 13 (01) : 1 - 12
  • [50] Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
    Roth, Gael
    Teyssier, Yann
    Benhamou, Maxime
    Abousalihac, Melodie
    Caruso, Stefano
    Sengel, Christian
    Seror, Olivier
    Ghelfi, Julien
    Seigneurin, Arnaud
    Ganne-Carrie, Nathalie
    Gigante, Elia
    Blaise, Lorraine
    Sutter, Olivier
    Decaens, Thomas
    Nault, Jean-Charles
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (36) : 5324 - 5337